Fang Cheng

9PUBLICATIONS
6CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Haematological tumoursPredictive and prognostic markersTumour immunologyTraditional Chinese medicine and treatments
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (9)

|Mar 10, 2026
Interplay Between Psychological Burden, Economic Stress, and Quality of Life in Chronic Myeloid Leukemia Care: An Integrated Analysis.

Fang Cheng, Yu Zhu, Bingcheng Liu

|Feb 10, 2026
Efficacy and safety of 50 mg versus 100 mg daily frontline dasatinib therapy in chronic-phase chronic myeloid leukemia: a non-controlled, observational dose-comparative cohort study.

Fang Cheng, Fan Wang, Zheng Cui

|Sep 16, 2025
Impact of additional cytogenetic aberrations at diagnosis of chronic phase chronic myeloid leukemia.

Fang Cheng, Zheng Cui, Qiang Li

|Dec 08, 2022
Reply to "Plasma imatinib trough levels for predicting efficacy and toxicity in patients with chronic myeloid leukemia in chronic phase: Still a matter of debate!"

Fang Cheng, Fang Zeng, Qiang Li

|Oct 01, 2022
Imatinib dose optimization based on therapeutic drug monitoring in Chinese patients with chronic-phase chronic myeloid leukemia.

Fang Cheng, Fang Zeng, Qiang Li

|Sep 19, 2022
Tacrolimus Concentration Is Effectively Predicted Using Combined Clinical and Genetic Factors in the Perioperative Period of Kidney Transplantation and Associated with Acute Rejection.

Fang Cheng, Qiang Li, Zheng Cui

Pageof 2

Frequent Collaborators

5 joint publications

Weiming Li

3 joint publications

Yu Zhang

2 joint publications

Fang Zeng

1 joint publications

Kaiping Wang